Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 31.74
-0.998 %
$ 1.77 B
Market Cap
24.05
P/E
SUPN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization SUPN - Supernus Pharmaceuticals, Inc.
84.9 M
LAST VALUE
61.35%
2 YEAR CAGR
64.42%
5 YEAR CAGR
60.63%
10 YEAR CAGR